BOSTON (AP) — Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing and pricing practices.
The civil settlement announced Friday re…
Bristol-Myers Squibb Co. will close a plant in western Puerto Rico that makes heart disease and diabetes medicine, eliminating 400 jobs, reports AP (Nov. 8, 2007). The closure, due to reduced demand for the medication, will be completed at the end of 2008, said spokeswoman Carmen Velez. The plant, operating for 36 years, produces Pravachol for heart disease and …
…
Abilify has been approved for the treatment of schizophrenia. The new antipsychotic, which is said to offer a combination of proven efficacy and a favorable side-effect profile, is being marketed in a joint arrangement involving Bristol-Myers Squibb Co. and Otsuka America Pharmaceutical Inc. Schizophrenia affects more than 2 million Americans.
Related Results
Abilify approvalAbilify approvalNew AbilifyAbilify available as oral solutionNew ABILIFY formulation
…
Abilify is an antipsychotic medication. It works by changing the actions of chemicals in the brain. Abilify is used for treatment the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression). It is also used together with other medications to treat major depressive disorder in adults.Buy cheap Abilify online without prescriptionBefore you take Abilify, tell your doctor if you regularly use o…
